ICBCCS SSE Star Biology & Medicine ETF

ICBCCS SSE Star Biology & Medicine ETF is offered by ICBC, a leading player in the field of passive investments.

The ETF is listed in CNY.

European investors may incur additional costs for currency exchange and transaction fees.

No, ICBCCS SSE Star Biology & Medicine ETF does not comply with the EU UCITS investor protection directives.

The P/E ratio of ICBCCS SSE Star Biology & Medicine ETF is 45.69.

ICBCCS SSE Star Biology & Medicine ETF tracks the performance of the SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Gross.

ICBCCS SSE Star Biology & Medicine ETF is domiciled in CN.

The fund was launched on 8/8/2024.

The ICBCCS SSE Star Biology & Medicine ETF mainly invests in Information technology companies.

The NAV of ICBCCS SSE Star Biology & Medicine ETF amounts to 686,463.65 CNY.

The price-to-book ratio is 5.021.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.